Ellie Kincaid

Hindawi reveals process for retracting more than 8,000 paper mill articles

Over the past year, amid announcements of thousands of retractions, journal closures and a major index delisting several titles, executives at the troubled publisher Hindawi have at various times mentioned a “new retraction process” for investigating and pulling papers “at scale.” The publisher has declined to provide details – until now.

So far in 2023, Hindawi has retracted over 8,000 articles – more than we’ve ever seen in a single year from all publishers combined. And Hindawi is not done cleaning up from paper mills’ infiltration of its special issues, according to a new report from its parent company, Wiley.

Reckoning with Hindawi’s paper mill problem has cost Wiley, which bought the open-access publisher in 2021, an estimated $35-40 million in lost revenue in the current fiscal year, Matthew Kissner, Wiley’s interim president and CEO, said on the company’s most recent earnings call. Wiley will stop using the “Hindawi” name next year, Kissner told investors.

The publisher has issued a whitepaper, “Tackling publication manipulation at scale: Hindawi’s journey and lessons for academic publishing,” which explains “what happened at Hindawi” and the process the company developed to investigate and retract thousands of articles from special issues.

Former Stanford president retracts Nature paper as another gets expression of concern

Marc Tessier-Lavigne, the former president of Stanford University who resigned earlier this year after an institutional research misconduct investigation, has retracted a paper from Nature. The journal’s editorial office marked another of Tessier-Lavigne’s articles with an expression of concern.

The two Nature papers – which have together been cited more than 1,000 times, according to Clarivate’s Web of Science – were among five the university investigation examined on which Tessier-Lavigne was the principal author. The other three have been retracted – two from Science and one from Cell. In a statement posted to his lab website July 19, Tessier-Lavigne wrote that he planned to correct the two papers in Nature.

The retracted article, “APP binds DR6 to trigger axon pruning and neuron death via distinct caspases,” appeared in 2009. It has been cited 816 times, according to Clarivate’s Web of Science. The retraction notice stated:

Journal retracts 31 papers, bans authors and reviewers after losing its impact factor

A journal that lost its impact factor and spot in a major index this year has made good on a promise to retract dozens of papers with “compromised” peer review.

Genetika, a publication of the Serbian Genetics Society, did not receive an updated impact factor this year after Clarivate, the company behind the closely-watched but controversial metric, identified signs of citation stacking, a practice in which authors or journals seem to trade citations. Clarivate also dropped Genetika from its Web of Science index for failing to meet editorial quality criteria.

Clarivate’s actions followed a blog post by scientific sleuth Elisabeth Bik about what she called the “Iranian Plant Paper Mill, which included 31 papers published in Genetika.

BMJ retracts article about effect of UK sugar tax after authors find error

The British Medical Journal has retracted an article that found UK households bought 10% less sugar in the form of soft drinks after the government started taxing the manufacturers on the sugar in their products.

The authors of the paper found an error in their analysis when following up on the work, and republished a corrected version – with less flashy results – in BMJ Open.

The original article, “Changes in soft drinks purchased by British households associated with the UK soft drinks industry levy: controlled interrupted time series analysis,” appeared in March 2021. It has been cited 84 times in the scientific literature, according to Clarivate’s Web of Science, as well as by media outlets and by policy documents for the UK government and World Health Organization.

Wiley to stop using “Hindawi” name amid $18 million revenue decline

Wiley will cease using the beleaguered Hindawi brand name, the publisher announced on an earnings call Wednesday morning. Wiley plans to integrate Hindawi’s approximately 200 journals into the rest of its portfolio by the middle of next year.

Problems with Hindawi, the open access publisher that Wiley acquired in 2021, have cost the company $18 million in revenue in its latest financial quarter compared to the same quarter of last year, Wiley also disclosed. Hindawi’s journals have been overrun by paper mills and published “meaningless gobbledegook,” in the words of one sleuth, leading to thousands of retractions, journal closures and a major index delisting several titles.

In the current fiscal year, Wiley expects $35-40 million in lost revenue from Hindawi as it works to turn around journals with issues and retract articles, Matthew Kissner, Wiley’s interim president and CEO, said on the earnings call. The company expects revenue to begin to recover in its next fiscal year, he said.

Elsevier investigating articles linked to controversial French researcher

The publisher Elsevier is investigating an unspecified number of articles by authors affiliated with a French research institute for concerns about “the appropriate conduct of research involving human participants.”

According to a “Publisher’s Note” that appeared November 9 in Elsevier’s New Microbes and New Infections, “concerns have been raised about a number of articles” published in the journal by researchers affiliated with the Institut Hospitalo-Universitaire Méditerranée Infection (IHU-MI) in Marseille.

The journal and Elsevier’s “Research Integrity and Publishing Ethics Centre of Expertise” are investigating the allegations “by confidentially consulting with the authors and, where necessary, liaising with the institution where the studies took place,” the note said. It continued:

Purdue agrees to pay feds back $737,000 for grant submissions with fake data

Purdue University has reached a settlement with the federal government to pay back grant money the institution received through applications submitted with falsified data, according to the U.S. Attorney’s Office for the Northern District of Indiana.

The settlement resolves allegations under the False Claims Act related to the case of Alice C. Chang (who also uses the name Chun-Ju Chang), a former associate professor of basic medical sciences at Purdue’s College of Veterinary Medicine in West Lafayette, In. Inside Higher Ed reported first on the settlement.

Last December, the U.S. Office of Research Integrity found Chang had faked data in two published papers and nearly 400 images across 16 grant applications. As we reported then:

Professor who sued employer for discrimination refiles after judge dismissed his suit

A professor at the University of Pittsburgh who sued the institution for racial discrimination and retaliation has refiled his suit after a federal judge dismissed his claims.

As we’ve previously reported, Moses Bility, an assistant professor of infectious diseases and microbiology in the university’s School of Public Health, sued the school earlier this year.

Among many claims of racial discrimination, Bility alleged the school’s response to a 2020 paper he published and later withdrew that proposed jade amulets may prevent COVID-19 was discriminatory. (In the process of our previous reporting on the article, Bility accused Retraction Watch of racism.)

According to Bility’s complaint, Pitt officials demanded an investigation of his research, which found he “did not violate any academic integrity standard.” However, at a departmental town hall meeting over Zoom, presenting the investigation’s findings, “students in Defendant Pitt’s School of Public Health called Dr. Bility derogatory names, such as stupid, retarded, unintelligent, etc.” Bility later received two emails “from anonymous individuals who Dr. Bility assumes came from the Defendant Pitt community” that included racial slurs.

Auburn PhD student faked data in grant application and published paper, feds say

A former PhD student at Auburn University in Alabama relabeled and reused images inappropriately in a grant application, published paper, and several presentations, a U.S. government watchdog has found.

The Office of Research Integrity says Sarah Elizabeth Martin “engaged in research misconduct by intentionally or knowingly falsifying and/or fabricating experimental data and results obtained under different experimental conditions,” according to a case summary posted online.

The published paper, “The m6A landscape of polyadenylated nuclear (PAN) RNA and its related methylome in the context of KSHV replication,” appeared online in advance of publication in RNA in June 2021. The journal retracted the article last year, with the following notice:

Authors hire lawyer as journal plans to retract their article on pesticide poisoning

A public health journal intends to retract an article that estimated how many unintentional pesticide poisonings happen each year worldwide, Retraction Watch has learned.

In response, the authors hired a lawyer to represent them in contesting the retraction, and maintain the journal’s decision “undermines the integrity of the scientific process.” This is the second time within a few months that the journal retracted an article through a process authors said was problematic.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: